ArticleCurrent microbiology2026
Surface Layer-Associated Protein on Nanoparticles from Lactobacillus helveticus Enhances the Response to LPS in RAW264.7 Cells.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Extracellular vesicle-like nanoparticles from Lactobacillus delbrueckii protect keratinocyte barrier function with involvement of TRPV4 signaling.World journal of microbiology & biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Lactic acid bacteria that persist in the gastrointestinal tract contribute not only to nutrient metabolism but also to the regulation of immune responses. Accordingly, these microorganisms and their components are classified as probiotics when administered in adequate amounts and shown to confer health benefits on the host. However, the mechanisms by which they interact with host cells remain poorly understood. Extracellular vesicles (EVs) have been shown to modulate functions in recipient cells, including both mammalian cells and microorganisms. Surface-layer associated proteins (SLAPs) are preferentially produced by Gram-positive syntrophic bacteria and are secreted to associate with the cell envelope. The dysfunction of SLAPs leads to disruption of the cell envelope, cell division, and cell-cell communication. In this study, we identified SLAP in extracellular vesicle-like nanoparticles (EV-LNPs) derived from Lactobacillus helveticus strain GIF001 (closed to strain VHProbi Y21) and observed enhanced immune responses-including nitric oxide and interleukin-6 production-in RAW264.7 cells when SLAP was added to the culture medium, either in the form of EV-LNPs or as a purified protein. Notably, L. helveticus EV-LNPs were internalized within 3 h and enhanced NF-κB signaling in response to lipopolysaccharide. Intracellular overexpression of SLAP led to increased activity of the inducible nitric oxide synthase promoter about 1.5 times, whereas deletion of the SLAP domain abolished this enhancement. Incubation of RAW264.7 cells with EV-LNPs or SLAP enhanced the uptake of Escherichia coli. These results suggest that EV-LNPs from L. helveticus may upregulate immune responses by activating host cell communication via SLAP.
Indexed as
Identifiers
41721904What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.